Butterfly Network (BFLY) Cash from Investing Activities (2020 - 2026)
Butterfly Network (BFLY) posted Cash from Investing Activities of -$974000.0 for Q2 2026, down 2.53% sequentially from -$950000.0 in Q1 2026, and down 8.71% YoY from -$1.1 million in Q2 2025.
Butterfly Network (BFLY) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Butterfly Network has reported Cash from Investing Activities for 7 years, with the latest figure at -$974000.0 in Q2 2026.
- Quarterly Cash from Investing Activities fell 8.71% year-over-year to -$974000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.0 million (down 94.35% YoY) and the FY2025 annual result came in at -$3.3 million, down 25.96% from the prior year.
- Cash from Investing Activities fell to -$974000.0 in Q2 2026 per BFLY's latest filing, from -$950000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $74.9 million in Q1 2023 and troughed at -$79.7 million in Q3 2022.
- A 5-year average of -$1.7 million and a median of -$995000.0 in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities jumped 1761.23% in 2023, then tumbled 169.12% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$2.5 million in 2022, then dropped by 1.25% to -$2.5 million in 2023, then surged by 83.76% to -$408000.0 in 2024, then tumbled by 165.44% to -$1.1 million in 2025, then rose by 10.06% to -$974000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$974000.0, -$950000.0, and -$1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Butterfly Network | 2.49 Bn | 2.36 Bn | 23.29 Mn | -974,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -974,000.00 |
| Jun 30, 2026 | -974,000.00 |
| Mar 31, 2026 | -950,000.00 |
| Mar 31, 2026 | -950,000.00 |
| Dec 31, 2025 | -1.08 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | -896,000.00 |
| Jun 30, 2025 | -896,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Dec 31, 2024 | -408,000.00 |
| Dec 31, 2024 | -408,000.00 |
| Sep 30, 2024 | -413,000.00 |
| Sep 30, 2024 | -413,000.00 |
| Jun 30, 2024 | -699,000.00 |
| Jun 30, 2024 | -699,000.00 |
| Mar 31, 2024 | -1.14 Mn |
| Mar 31, 2024 | -1.14 Mn |